July 6, 2023 MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke
July 6, 2023 MedRhythms Announces FDA Listing of InTandem™ (MR-001) to Improve Walking and Ambulation in Adults with Chronic Stroke
March 8, 2023 KOL Event on Next-Generation Neurotherapeutics: Leveraging the Power of Music and Technology
March 8, 2023 KOL Event on Next-Generation Neurotherapeutics: Leveraging the Power of Music and Technology
December 7, 2022 MedRhythms Recognized for Advancements in Prescription Digital Therapeutics from CB Insights, Reuters Events Pharma and Fast Company
December 7, 2022 MedRhythms Recognized for Advancements in Prescription Digital Therapeutics from CB Insights, Reuters Events Pharma and Fast Company
January 18, 2022 Digital Therapeutics Alliance Appoints MedRhythms Co-Founder Owen McCarthy to Chair Board of Directors
January 18, 2022 Digital Therapeutics Alliance Appoints MedRhythms Co-Founder Owen McCarthy to Chair Board of Directors
December 9, 2021 MedRhythms Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
December 9, 2021 MedRhythms Named to the 2021 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
November 16, 2021 MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round
November 16, 2021 MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B Round